JHL Biotech ropes in new CFO

BioSpectrum (Asia) - - People News -

Tai­wan based JHL Biotech re­cently an­nounced the ap­point­ment of El­lis Chu as its Chief Fi­nan­cial Of­fi­cer (CFO). Chu most re­cently served as a Manag­ing Direc­tor and the Head of Greater China at Ion Pa­cific, an Asi­afo­cused ven­ture cap­i­tal mer­chant bank. Prior to Ion Pa­cific, he spent the bulk of his ca­reer in in­vest­ment bank­ing, in­clud­ing serv­ing as Head of China Merg­ers & Ac­qui­si­tions at Bank of Amer­ica Mer­rill Lynch.

He also held se­nior in­vest­ment bank­ing po­si­tions at Cit­i­group, No­mura and Lehman Broth­ers ad­vis­ing on trans­ac­tions across mul­ti­ple sec­tors, in­clud­ing health­care. Chu holds a B.S. in Elec­tri­cal Engi­neer­ing from North­west­ern Univer­sity and an MBA from Columbia Busi­ness School.

At the same time, JHL Biotech has raised $106 mil­lion in a con­vert­ible bond is­suance. Pro­ceeds raised from the is­suance will be used for clin­i­cal tri­als, work­ing cap­i­tal needs and fur­ther de­vel­op­ment of the com­pany’s pipeline of biosim­i­lar treat­ments.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.